The latest coronavirus strain, XEC, makes up 17%. It is another descendant from the Omicron family, according to Yale ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The study was based on outcomes seen among essential workers with COVID-19 infection from June 2021 to September 2022.

Nirmatrelvir-ritonavir effectively lowers hospitalization rates and long COVID symptoms in non-hospitalized, high-risk patients with mild to moderate COVID-19.

Scientists headed by a team at the Icahn School of Medicine at Mount Sinai have developed ... including the most recent Omicron variants of SARS-CoV-2. “AMETA’s flexible design allows it ...

which is a combination of two previous omicron strains, may mean the vaccines prepared to bolster people in the colder months won’t be as effective. Dr Scott Roberts, MD, a Yale Medicine ...

Most participants in this study were infected with the Omicron variant. Researchers, led by Carolyn Bramante, MD, MPH, an internist, pediatrician, and obesity medicine specialist at the University ...

meaning it's a "hybrid resulting from a merger and rearrangement of two pre-existing COVID subvariants," according to Yale Medicine. But since both of those subvariants are part of the Omicron ...

Researchers at Kumamoto University have made a significant breakthrough in the fight against COVID-19 with the development of ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

The study, led by Dr. Teresa Evering, assistant professor of medicine in the division of ... against COVID-19 and enrolled before omicron variants of the SARS-CoV-2 virus emerged.